Zynex Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
In: Health & Medicine Week, 2024-06-07, S. 10559-10559
serialPeriodical
Zugriff:
Zynex Inc., a medical technology company, has filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on May 17, 2024. The company's SIC code is 3845, which corresponds to Electromedical and Electrotherapeutic Apparatus. The SEC filing is a statement of changes in beneficial ownership of securities and provides information on the reporting person's relationship to the company and purchases and sales of equity securities. For more details, the SEC filing can be accessed through the provided link. [Extracted from the article]
Copyright of Health & Medicine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Zynex Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
|
---|---|
Zeitschrift: | Health & Medicine Week, 2024-06-07, S. 10559-10559 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6459 (print) |
Sonstiges: |
|